Yep - pretty solid update IMO.
There was no $$ figure mentioned for the Statutory NPAT in the second half (1st half = $9m), but they did say they will report this about 1 months time with the annual report (obviously).
A few highlights were:
- Revenue for FY23 was $230m – up 60% from $143m last year).
- Cost savings of $20m pa following the Society One acquisition.
- Office operating cost to income ratio now less that 25% (down from 40% in FY22).
- Gross customer receivable now $1.1b showing lower originations (was $1.3b).
- Originations in Q4 = $127m (up from $98m in Q3).
- Equifax score continuing to increase & is now 724 (was 704 in FY22).
- Secured assets now up to 43% (up from 38% in FY22).
- Quarterly nett losses continued to reduce & were 5.6% in Q4 (was 5.9% in Q3). But these Q4 nett losses are still higher than FY22.
- Repayment of $25m in debt from CR proceeds, and now have better loan terms ($6m pa interest savings).
- Extension of the Autopay warehouse until October 2024 (which is towards the end of next year - not this year).
- New $150m personal loan securitisation deal in Q4.
- Unrestricted cash = $16m (was $14m in Q3).
- Cash position expected to increase further in FY24 due to cash optimisation savings & lower interest costs.
- Forums
- ASX - By Stock
- Ann: 4Q23 Trading Update
MME
moneyme limited
Add to My Watchlist
3.13%
!
15.5¢

Yep - pretty solid update IMO. There was no $$ figure mentioned...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $124.0M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 14.0¢ | $65.51K | 434.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11475 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 333024 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 401815 | 0.135 |
2 | 106827 | 0.130 |
5 | 306000 | 0.125 |
2 | 30000 | 0.120 |
1 | 45000 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 320000 | 2 |
0.165 | 407868 | 6 |
0.170 | 148943 | 8 |
0.175 | 125554 | 1 |
0.180 | 73750 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
MME (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online